Cardinal Health, Inc. · NYSE:CAH
Cardinal Health — Shareholder Meeting (November 2024)
14 slides from Cardinal Health's shareholder meeting presentation, Nov 6, 2024
Slide 1: Cardinal Health Annual Meeting of Shareholders
Cardinal Health Annual Meeting of Shareholders November 6, 2024 © 2024 Cardinal Health. All Rights Reserved. 1 © 2024 Cardinal Health. All Rights Reserved.
Slide 2: Agenda
• Cardinal Health Annual Meeting of Shareholders Agenda I. Call to Order II. Matters to be Acted Upon o Proposal 1: Election of Directors o Proposal 2: Advisory vote to approve the compensation of our named executive officers o Proposal 3: Ratification of Ernst & Young LLP as independent auditor for
Slide 3: Management presentation from CEO Jason Hollar
Management presentation from CEO Jason Hollar November 6, 2024 © 2024 Cardinal Health. All Rights Reserved. 3 © 2024 Cardinal Health. All Rights Reserved.
Slide 4: Cautions Concerning Forward-Looking Statements
• Cardinal Health Annual Meeting of Shareholders Cautions Concerning Forward-Looking Statements This presentation contains forward-looking statements addressing expectations, prospects, estimates and other matters that are dependent upon future events or developments. These statements may be identif
Slide 5: Healthcare's crucial link
• Cardinal Health Annual Meeting of Shareholders Healthcare’s crucial link ~90% 40K+ U.S. hospitals served pharmaceutical deliveries a day 20K 20+ specialty physician product categories as integrated offices and clinics medical manufacturer 5K+ 30 sourcing/manufacturer partners across the PET cyclot
Slide 6: Company snapshot
• Cardinal Health Annual Meeting of Shareholders Company snapshot Operating in more than Approximately $227B 30 48,000 in FY24 Revenue countries employees globally Pharma & Specialty GMPD FY24 Revenue: $210.0B FY24 Revenue: $12.4B FY24 Segment Profit: $2.0B FY24 Segment Profit: $92M Other FY24 Reven
Slide 7: FY24 highlights
• Cardinal Health Annual Meeting of Shareholders FY24 highlights Strategy, operations and Capital FY24 financial deployment performance Governance portfolio Announced company Returned $1.25B Delivered record non-GAAP Appointed new independent reorganization to shareholders in FY24 EPS, growth of 29%
Slide 8: Strategic priorities
• Cardinal Health Annual Meeting of Shareholders Strategic priorities Ruthless prioritization, resilient core and relentless focus 1 Build upon the Execute GMPD Accelerate Relentless growth and resiliency of Pharmaceutical and Specialty 2 Improvement Plan initiatives 3 growth in key areas 4 focus on
Slide 9: Enabling a healthier and more sustainable world
Enabling a healthier and more sustainable world Our seven DrivingESG priorities sustainable serve impact is anas the foundation important way to buildofcustomer our efforts to enable trust and a healthier strengthen future for our communities, our businesses customers and employees Community Diversi
Slide 10: Thank you and questions
Thank you and questions 10 © 2024 Cardinal Health. All Rights Reserved.
Slide 11: Appendix
Appendix 11 © 2024 Cardinal Health. All Rights Reserved.
Slide 12: Segment Information
Cardinal Health, Inc. and Subsidiaries Segment Information Fourth Quarter Pharmaceutical and Specialty Solutions Global Medical Products and Distribution Other (in millions) 2024 2023 2024 2023 2024 2023 Revenue Amount $ 55,608 $ 49,373 $ 3,109 $ 3,047 $ 1,172 $ 1,020 Growth rate 13 % 15 % 2% (2)% 1
Slide 13: GAAP / Non-GAAP Reconciliation
Cardinal Health, Inc. and Subsidiaries 1 GAAP / Non-GAAP Reconciliation Gross Operating Earnings Net Diluted 2 3 3 Margin SG&A Earnings Before Provision for Earnings Effective EPS Gross Growth Growth Operating Growth Income Income Net Growth Tax Diluted Growth 2 3 3 Margin Rate SG&A Rate Earnings Ra
Slide 14: GAAP Cash Flow to Non-GAAP Adjusted Free Cash Flow
Cardinal Health, Inc. and Subsidiaries GAAP / Non-GAAP Reconciliation - GAAP Cash Flow to Non-GAAP Adjusted Free Cash Flow Fiscal Year Fiscal Year (in millions) 2024 2023 GAAP - Cash Flow Categories Net cash provided by operating activities $ 3,762 $ 2,844 Net cash provided by/(used in) investing ac
Cardinal Health — Shareholder Meeting (November 2024) on 6ix